Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Follow-Up Appointments: If your treatment involves a series of sessions, make sure to attend your follow-up appointments as scheduled for optimal results
Retatrutide is an unapproved investigational triple agonist (GLP-1, GIP, glucagon receptors) not licensed by the MHRA, EMA, or FDA for routine clinical use
Top customer reviews Good for Immune SystemI have been taking this for a year as an antioxidant and to strengthen my immune system
Long-term studies in animals to evaluate carcinogenic potential have not been done
This range works well for long-term maintenance programs once initial improvement goals are achieved
US$ 20.65
US$ 24.45
US$ 22.64
US$ 26.66
US$ 20.19
US$ 20.72
US$ 25.98
